Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Disc Medicine (IRON), and Recursion Pharmaceuticals (RXRX) are making meaningful pipeline progress, with key clinical and regulatory catalysts ahead in 2026, Morgan Stanley said in a note Monday.

Detailed price information for Relay Therapeutics Inc (RLAY-Q) from The Globe and Mail including charting and trades.

OpenAI's chief economist, Ronnie Chatterji, emphasizes analytical expertise, adaptability, collaboration, and independent ...

While technology leaders and sci-fi writers envision a “technological singularity”—a threshold where artificial ...

Ronnie Chatterji leads a team of researchers at the company who study how AI is affecting workers, employers, and the economy ...

AI-driven microfactories gain momentum as private investment, industrial policy and automation accelerate decentralized ...

Sixty-nine-year-old Wynd Kaufmyn, a retired teacher from Berkeley, California, is believed to be the first person imprisoned for protesting the development of artificial intelligence, after she and ...

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most ...

At OpenAI, figuring out how artificial intelligence will transform the labor market has become a moving target, with the ...

The ultimate success or failure of the entire industry landscape ultimately hinges on the fiercely competitive enterprise ...

As AI evolves to autonomously generate full-fledged software programs, immersive interactive games, functional smart city ...